GlaxoSmithKline to raise India unit stake in Rs 52.2b deal

Tags: Companies
GlaxoSmithKline Plc plans to buy up to an additional 31.8 percent stake in its Indian consumer products arm for about 52.2 billion rupees, as Britain's biggest drugmaker deepens its emerging markets and non-prescription consumer health footprint.

GlaxoSmithKline plans to raise its stake in GlaxoSmithKline Consumer Healthcare Ltd to 75 percent from 43.2 percent, paying 3,900 rupees per share through an open offer, it said in a statement.

The price represents a premium of 28 percent to the stock's Friday close.

The news sent shares of GSK Consumer Healthcare to a record high. The shares were locked at 3,659.20 rupees, up 20 percent, their maximum daily trading limit, while the Mumbai market was up 0.23 percent, by 11:30 a.m.

"This transaction represents a further step in GSK's strategy to invest in the world's fastest growing markets," David Redfern, chief strategy officer at GlaxoSmithKline, said in the statement.

The company, however, has "no current plans" to launch an open offer for its Indian drugs unit GlaxoSmithKline Pharmaceuticals Ltd, he added.

HORLICKS PLAN

Tough market conditions in Europe have hampered GSK's hopes for a return to sales growth this year, although the company's growing business in emerging markets and its large consumer healthcare operation are both doing well.

In India, for example, sales of the consumer unit's flagship Horlicks brand stood at 270 million pounds in the year that ended December 2011, contributing to nearly three-quarters of its total revenues.

"A lot of the current business of Horlicks is in the south and the east of India. So there is still a great opportunity to increase the penetration to the north and the west," Redfern told Reuters in an interview, adding that the company intended to introduce new variants of the brand in the country.

GlaxoSmithKline does not plan to delist the unit.

Securities regulations in India require a minimum public shareholding of 25 percent for a company to maintain a public listing.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Sebi must issue strict guidelines on research reports and stock tips by brokers

    After prescribing a corporate governance code for companies, capital market regulator, Securities and Exchange Board of India (Sebi) is drafting prude

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Roopen Roy

Myanmar must realise its importance

Myanmar is not just one of the neighbours of India. ...

Rajgopal Nidamboor

Of life, harmony and divine insight

We are all endowed with energy — something we don’t ...

Gautam Gupta

Moral policing is the need of the hour

Recently, when Deepika Padukone raised her voice against an objectionable ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture